Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study.
Luigi Angelo Vaira,Claire Hopkins,Marzia Petrocelli,Jerome R. Lechien,Carlos M. Chiesa-Estomba,Giovanni Salzano,Marco Cucurullo,Francesco Antonio Salzano,Sven Saussez,Paolo Boscolo-Rizzo,Federico Biglioli,G De Riu +11 more
Reads0
Chats0
TLDR
Chemosensitive disturbances persisted in 7.2 per cent of patients 60 days after clinical onset and specific therapies should be initiated in patients with severe olfactory and gustatory disturbances 20 days after disease onset.Citations
More filters
Journal ArticleDOI
Long covid-mechanisms, risk factors, and management.
TL;DR: In this article, a review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure, including fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of posttraumatic stress disorder, muscle pain, concentration problems, and headache.
Journal ArticleDOI
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.
Destin Groff,Ashley Sun,Anna E. Ssentongo,Djibril M. Ba,Nicholas Parsons,Govinda Poudel,Alain Lekoubou,John S. Oh,Jessica E. Ericson,Paddy Ssentongo,Paddy Ssentongo,Vernon M. Chinchilli +11 more
TL;DR: More than half of COVID-19 survivors experienced persistent postacute sequelae (PASC) 6 months after recovery as mentioned in this paper, and most common PASC involved functional mobility impairments, pulmonary abnormalities, and mental health disorders.
Journal ArticleDOI
Symptoms, complications and management of long COVID: a review.
Olalekan Lee Aiyegbusi,Sarah E. Hughes,Sarah E. Hughes,Grace M Turner,Samantha Cruz Rivera,Christel McMullan,Joht Singh Chandan,Shamil Haroon,Gary Price,Elin Haf Davies,Krishnarajah Nirantharakumar,Elizabeth Sapey,Melanie Calvert +12 more
TL;DR: The most prevalent reported symptoms were fatigue, shortness of breath, muscle pain, joint pain, headache, cough, chest pain, altered smell, altered taste and diarrhoea.
Journal ArticleDOI
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
TL;DR: A systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection was conducted by as mentioned in this paper, where the authors defined persistent symptoms as those persisting for at least 60 days after diagnosis, symptom onset, or hospitalization or at least 30 days after recovery from the acute illness or hospital discharge.
Journal ArticleDOI
Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19
Luigi Angelo Vaira,Jerome R. Lechien,Giovanni Salzano,Francesco Antonio Salzano,Fabio Maglitto,Sven Saussez,Giacomo De Riu +6 more
TL;DR: According to the psychophysical evaluations, it can be inferred that the pathogenesis of taste disorders in COVID-19 patients is largely smell-independent, and it is essential that gustatory dysfunctions, like olfactory disorders, are included in the CO VID-19 guidelines.
References
More filters
Journal ArticleDOI
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Jerome R. Lechien,Carlos M. Chiesa-Estomba,Daniele R De Siati,Mihaela Horoi,Serge D Le Bon,Alexandra Rodriguez,Didier Dequanter,Serge Blecic,Fahd El Afia,Lea Distinguin,Younes Chekkoury-Idrissi,Stéphane Hans,Irene Lopez Delgado,Christian Calvo-Henriquez,Philippe Lavigne,Chiara Falanga,Maria Rosaria Barillari,Giovanni Cammaroto,Mohamad Khalife,Pierre Leich,Christel Souchay,Camelia Rossi,Fabrice Journe,Julien Hsieh,Myriam Edjlali,Myriam Edjlali,Robert Carlier,Laurence Ris,Andrea Lovato,Cosimo de Filippis,Frédérique Coppée,Nicolas Fakhry,Tareck Ayad,Sven Saussez +33 more
TL;DR: Olfactory and gustatory disorders are prevalent symptoms in European CO VID-19 patients, who may not have nasal symptoms, and the sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection.
Journal ArticleDOI
Corticosteroid Therapy for Critically Ill Patients With Middle East Respiratory Syndrome
Yaseen M. Arabi,Yasser Mandourah,Fahad Al-Hameed,Anees Sindi,Ghaleb A. Almekhlafi,Mohamed A. Hussein,Jesna Jose,Ruxandra Pinto,Awad Al-Omari,Ayman Kharaba,Abdullah Almotairi,Al Khatib K,Basem Alraddadi,Sarah Shalhoub,Ahmed Abdulmomen,Ismeal Qushmaq,Ahmed Mady,Othman Solaiman,Abdulsalam M. Al-Aithan,Rajaa Al-Raddadi,Ahmed Ragab,Hanan H. Balkhy,Al Harthy A,Ahmad M. Deeb,Al Mutairi H,Abdulaziz Al-Dawood,Laura Merson,Frederick G. Hayden,Frederick G. Hayden,Rob Fowler +29 more
TL;DR: Corticosteroid therapy in patients with MERS was not associated with a difference in mortality after adjustment for time‐varying confounders but was associated with delayed MERS coronavirus RNA clearance.
Journal ArticleDOI
Smell dysfunction: a biomarker for COVID-19.
Shima T. Moein,Seyed Mohammadreza Hashemian,Babak Mansourafshar,Ali Khorram‐Tousi,Payam Tabarsi,Richard L. Doty +5 more
TL;DR: Severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), is responsible for the largest pandemic since the 1918 influenza A virus subtype H1N1 influenza outbreak.
Journal ArticleDOI
Anosmia and Ageusia: Common Findings in COVID-19 Patients.
TL;DR: In a not negligible number of patients affected by COVID‐19 (coronavirus disease 2019), especially if paucisymptomatic, anosmia and ageusia can represent the first or only symptomatology present, it is necessary to select patients suitable for surgery on the basis of prior history and once they provide informed consent for surgery.
Journal ArticleDOI
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.
Giacomo Spinato,Cristoforo Fabbris,Jerry Polesel,Diego Cazzador,Daniele Borsetto,Claire Hopkins,Paolo Boscolo-Rizzo +6 more
TL;DR: This study reports on the prevalence, intensity, and timing of an altered sense of smell or taste in patients with SARS-CoV-2 infections.
Related Papers (5)
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Jerome R. Lechien,Carlos M. Chiesa-Estomba,Daniele R De Siati,Mihaela Horoi,Serge D Le Bon,Alexandra Rodriguez,Didier Dequanter,Serge Blecic,Fahd El Afia,Lea Distinguin,Younes Chekkoury-Idrissi,Stéphane Hans,Irene Lopez Delgado,Christian Calvo-Henriquez,Philippe Lavigne,Chiara Falanga,Maria Rosaria Barillari,Giovanni Cammaroto,Mohamad Khalife,Pierre Leich,Christel Souchay,Camelia Rossi,Fabrice Journe,Julien Hsieh,Myriam Edjlali,Myriam Edjlali,Robert Carlier,Laurence Ris,Andrea Lovato,Cosimo de Filippis,Frédérique Coppée,Nicolas Fakhry,Tareck Ayad,Sven Saussez +33 more